Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO : revenue, balance sheet and financial ratios

SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO is a French company founded 10 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in BOIS-GUILLAUME (76230), this company of category PME shows in 2024 a net income positive of 82 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO (SIREN 819939422)
Indicator 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C
Net income 82 009 € 382 012 € 618 685 € 267 258 € 64 665 €
EBITDA N/C N/C N/C -2 632 € -4 808 €
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO generates positive net income of 82 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 65 k€ -> 82 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

82 009 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 91%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

9.971%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

90.861%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.4%

Solvency indicators evolution
SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO

Sector positioning

Debt ratio
9.97 2024
2022
2023
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Good +18 pts over 3 years

In 2024, the debt ratio of SPFPL DE BIOLOGISTES MEDI... (9.97) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
90.86% 2024
2022
2023
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Excellent

In 2024, the financial autonomy of SPFPL DE BIOLOGISTES MEDI... (90.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 15950.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

15950.978

Liquidity indicators evolution
SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO

Sector positioning

Liquidity ratio
15950.98 2024
2022
2023
2024
Q1: 132.35
Med: 897.73
Q3: 5412.13
Excellent

In 2024, the liquidity ratio of SPFPL DE BIOLOGISTES MEDI... (15950.98) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO

Positioning of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 230 336€ to 1 589 219€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
230k€ 1064k€ 1589k€
1 064 291 € Range: 230 336€ - 1 589 219€
NAF 5 année 2024

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO

What is the revenue of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO ?

The revenue of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO profitable?

Yes, SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO generated a net profit of 82 k€ in 2024.

Where is the headquarters of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO ?

The headquarters of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO is located in BOIS-GUILLAUME (76230), in the department Seine-Maritime.

Where to find the tax return of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO ?

The tax return of SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO operate?

SPFPL DE BIOLOGISTES MEDICAUX BIO-TREDANO operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.